<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   113
  </number>
  <updateDate>
   2023-01-11T13:43:43Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:43:43Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-01-04
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 2 (Monday, January 4, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. JACKSON LEE:H.R. 113.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8, Clause 1 of the UnitedStates Constitution.[Page H54]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-03T00:26:54Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-04T15:16:15Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-01-04
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-01-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     J000032
    </bioguideId>
    <fullName>
     Rep. Jackson Lee, Sheila [D-TX-18]
    </fullName>
    <firstName>
     SHEILA
    </firstName>
    <lastName>
     JACKSON LEE
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     18
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     W000808
    </bioguideId>
    <fullName>
     Rep. Wilson, Frederica S. [D-FL-24]
    </fullName>
    <firstName>
     Frederica
    </firstName>
    <lastName>
     Wilson
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     S.
    </middleName>
    <district>
     24
    </district>
    <sponsorshipDate>
     2021-02-04
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Cancer
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Health information and medical records
     </name>
    </item>
    <item>
     <name>
      Health programs administration and funding
     </name>
    </item>
    <item>
     <name>
      Health promotion and preventive care
     </name>
    </item>
    <item>
     <name>
      Medical education
     </name>
    </item>
    <item>
     <name>
      Medical research
     </name>
    </item>
    <item>
     <name>
      Minority health
     </name>
    </item>
    <item>
     <name>
      Research administration and funding
     </name>
    </item>
    <item>
     <name>
      Women's health
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-01-04
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-02-01T19:07:39Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Triple-Negative Breast Cancer Research and Education Act of 2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.&lt;/p&gt; &lt;p&gt;Specifically, the National Institutes of Health must conduct and support research into the disease.&lt;/p&gt; &lt;p&gt;Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Triple-Negative Breast Cancer Research and Education Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Triple-Negative Breast Cancer Research and Education Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Triple-Negative Breast Cancer Research and Education Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-01-04T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr113ih/xml/BILLS-117hr113ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-02
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
2021-01-04T15:16:15Z
Referred to
House
Energy and Commerce Committee
2021-02-03T00:26:54Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
W000808
24
Frederica
Rep. Wilson, Frederica S. [D-FL-24]
Wilson
S.
D
2021-02-04
FL
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-01-04
2021-02-02
Referred to the Subcommittee on Health.
House
Health
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
N
JACKSON LEE
D
TX
Cancer Government information and archives Health information and medical records Health programs administration and funding Health promotion and preventive care Medical education Medical research Minority health Research administration and funding Women's health
2021-01-04
Introduced in House
 <p><b>Triple-Negative Breast Cancer Research and Education Act of 2021</b></p> <p>This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.</p> <p>Specifically, the National Institutes of Health must conduct and support research into the disease.</p> <p>Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.</p>
2021-02-01T19:07:39Z
00
2021-01-04T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr113ih/xml/BILLS-117hr113ih.xml
Triple-Negative Breast Cancer Research and Education Act of 2021
Triple-Negative Breast Cancer Research and Education Act of 2021
Display Title
IH
Introduced in House
To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Triple-Negative Breast Cancer Research and Education Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:43:43Z
2023-01-11T13:43:43Z
3.0.0
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-04
9
Library of Congress
Introduced in House
IntroReferral
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
N
JACKSON LEE
D
TX
W000808
24
Frederica
Rep. Wilson, Frederica S. [D-FL-24]
Wilson
S.
D
2021-02-04
FL
Cancer Government information and archives Health information and medical records Health programs administration and funding Health promotion and preventive care Medical education Medical research Minority health Research administration and funding Women's health
2021-01-04
Introduced in House
 <p><b>Triple-Negative Breast Cancer Research and Education Act of 2021</b></p> <p>This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.</p> <p>Specifically, the National Institutes of Health must conduct and support research into the disease.</p> <p>Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.</p>
2021-02-01T19:07:39Z
00
Triple-Negative Breast Cancer Research and Education Act of 2021
Triple-Negative Breast Cancer Research and Education Act of 2021
Display Title
IH
Introduced in House
To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Triple-Negative Breast Cancer Research and Education Act of 2021
Short Title(s) as Introduced
2021-02-02
Referred to the Subcommittee on Health.